The report highlights Julphar's third consecutive year of ESG reporting, demonstrating their commitment to transparent disclosure across economic, governance, environmental, and social aspects. The report details Julphar's significant revenue growth in 2022, driven by a 24% increase in production volume and expansion into new markets. The report also emphasizes Julphar's focus on sustainability, including a 16.2% decrease in GHG emissions and a 3.6% reduction in water consumption. Julphar's efforts towards a diverse and inclusive workplace are highlighted, with a 6.7% increase in female workforce participation. Julphar's commitment to local communities is shown through initiatives like the Blood Donation Campaign, Seasonal Flu Vaccination, and the 'Touch of Hope' initiative.
Go back to company
Gulf Pharmaceutical Industries PSC 2022 ESG Report
Issuing Company Gulf Pharmaceutical Industries PSC
Report Type Sustainability Report
Report Language EN
Report Filesize 2.58 MB
No. of Pages 26 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report Edition3
Assurance Provider Unknown
Reporting Standards GRI 2021; Abu Dhabi Stock Exchange's ESG (ESG) Disclosure Guid...
Materiality Assessmenttrue